ArticleMolecular biology reports2025
Comparative viral load analysis of torque Teno virus and Torque teno mini virus in COVID-19 infected and non-infected individuals in the United Arab Emirates.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTorque teno virus (TTV) and Torque teno mini virus (TTMV) are highly prevalent, non-pathogenic viruses from the Anelloviridae family that commonly circulate in healthy individuals. Their replication dynamics are closely linked to the host immune status, with viral loads typically increasing during immune suppression or dysregulation associated with viral infections, transplantation, or chronic inflammation. Emerging evidence suggests that TTV may serve as a biomarker of immune competence, with increasing interest in its role during SARS-CoV-2 infection. This study investigated the presence of TTV and TTMV among the study samples, viral load (VL), and demographic associations of TTV and TTMV in COVID-19 infected and non-infected individuals in the United Arab Emirates (UAE).
methodsWe analysed 278 plasma samples, 139 COVID-19 infected samples and 139 non-infected samples, via species-specific nested PCR targeting conserved genomic regions downstream of the TATA box in the range of nucleotide positions 99–227 for TTV and 178–303 for TTMV. In-house clones constructed from non-infected COVID-19 samples served as positive controls for the detection and quantification of TTV and TTMV. Real-time qPCR was used to quantify the viral loads. Furthermore, demographic data, including age, BMI, and COVID-19 symptoms, were gathered, and statistically analysed.
resultsThe TTV-VL was significantly higher in COVID-19 infected individuals (p < 0.001), whereas the TTMV-VL was not significantly different between the groups (p = 0.948). No statistically significant correlation was found between TTV-VL and age or BMI in individual groups, although age-based subgroup analysis revealed notable differences in the co-infected study samples. In co-infected individuals (those harbouring both TTV and TTMV), TTV-VL remained significantly elevated in the COVID-19 infected groups, whereas TTMV-VL remained non-significant.
conclusionOur findings demonstrate that TTV-VL is elevated in association with COVID-19 infection, suggesting its potential as a marker of immune modulation during SARS-CoV-2 infection. In contrast, TTMV-VL appears to be unaffected by COVID-19 status, indicating different replication dynamics between these related viruses during immune challenge. This study advances our knowledge of the clinical relevance of TTV as a biomarker of immune function and offers the first thorough analysis of anelloviruses viral loads in UAE study samples in the context of COVID-19.
Indexed as
Identifiers
41284082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.